2'-Deoxytubercidin

2'-Deoxytubercidin

SCHEMBL14294692

Nc1ncnc2c1ccn2C1CC(O)C(CO)O1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 5/20 0.57
▸ PRMT5 O14744 2/20 0.56
▸ ADK P55263 2/20 0.55
▸ HIF1A Q16665 1/20 0.52
▸ PNP P00491 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ PDE4D Q08499 1/20 0.51
▸ PDE3A Q14432 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ ADORA3 P0DMS8 1/20 0.51
▸ ADORA2A P29274 1/20 0.51
▸ ADRB1 P08588 1/20 0.50
▸ DNMT1 P26358 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2'-Deoxytubercidin SCHEMBL5918784 1.00 METTL3 (0.57) METTL3PRMT5ADKHIF1APNP
2'-Deoxytubercidin SCHEMBL3229680 1.00 METTL3 (0.57) METTL3PRMT5ADKHIF1APNP
2'-Deoxytubercidin SCHEMBL7872096 1.00 METTL3 (0.57) METTL3PRMT5ADKHIF1APNP
2'-Deoxytubercidin SCHEMBL7872094 1.00 METTL3 (0.57) METTL3PRMT5ADKHIF1APNP
2'-Deoxytubercidin SCHEMBL23982116 1.00 METTL3 (0.57) METTL3PRMT5ADKHIF1APNP
2'-Deoxytubercidin SCHEMBL5918830 1.00 METTL3 (0.57) METTL3PRMT5ADKHIF1APNP
2'-Deoxytubercidin SCHEMBL23982321 1.00 METTL3 (0.57) METTL3PRMT5ADKHIF1APNP
2'-Deoxytubercidin SCHEMBL13314431 1.00 METTL3 (0.57) METTL3PRMT5ADKHIF1APNP
2'-Deoxytubercidin SCHEMBL14104716 1.00 METTL3 (0.57) METTL3PRMT5ADKHIF1APNP
SCHEMBL21625244 0.91 METTL3 (0.60) METTL3PRMT5ADKADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1406667-B1 METHODS FOR INCREASING IN VIVO EFFICACY OF OLIGONUCLEOTIDES AND INHIBITING INFLAMMATION IN MAMMALS TOPIGEN PHARMACEUTICALS INC (CA) 2008-02-20 — — EP disclosed
Send feedback